As of 2025-09-15, the Relative Valuation of IGM Biosciences Inc (IGMS) is (11.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.27 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -1017.2%.
The range of the Relative Valuation is (9.35) - (13.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 15.1x | 13.3x |
| Forward P/E multiples | 10.3x - 16.6x | 13.2x |
| Fair Price | (9.35) - (13.31) | (11.65) |
| Upside | -836.5% - -1148.0% | -1017.2% |
| Date | P/E |
| 2025-08-13 | -1.44 |
| 2025-08-12 | -1.48 |
| 2025-08-11 | -1.47 |
| 2025-08-08 | -1.44 |
| 2025-08-07 | -1.44 |
| 2025-08-06 | -1.46 |
| 2025-08-05 | -1.46 |
| 2025-08-04 | -1.48 |
| 2025-08-01 | -1.49 |
| 2025-07-31 | -1.44 |
| 2025-07-30 | -1.43 |
| 2025-07-29 | -1.43 |
| 2025-07-28 | -1.43 |
| 2025-07-25 | -1.44 |
| 2025-07-24 | -1.46 |
| 2025-07-23 | -1.46 |
| 2025-07-22 | -1.44 |
| 2025-07-21 | -1.46 |
| 2025-07-18 | -1.46 |
| 2025-07-17 | -1.44 |
| 2025-07-16 | -1.44 |
| 2025-07-15 | -1.54 |
| 2025-07-14 | -1.55 |
| 2025-07-11 | -1.55 |
| 2025-07-10 | -1.55 |
| 2025-07-09 | -1.54 |
| 2025-07-08 | -1.51 |
| 2025-07-07 | -1.54 |
| 2025-07-03 | -1.55 |
| 2025-07-02 | -1.50 |
| 2025-07-01 | -1.47 |
| 2025-06-30 | -1.27 |
| 2025-06-27 | -1.23 |
| 2025-06-26 | -1.39 |
| 2025-06-25 | -1.38 |
| 2025-06-24 | -1.34 |
| 2025-06-23 | -1.32 |
| 2025-06-20 | -1.33 |
| 2025-06-18 | -1.33 |
| 2025-06-17 | -1.35 |
| 2025-06-16 | -1.39 |